Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSL2400426	KL-A167注射液	tagitanlimab	Injection	Biological Products(1)	New Drug Application	2024-07-04		Sichuan Kelun-Biotech Biopharmaceutical Co Ltd			view
CXSL2300491	KL-A167注射液	tagitanlimab	Injection	Biological Products(1)	New Drug Application	2023-07-18		Sichuan Kelun-Biotech Biopharmaceutical Co Ltd			view
CXSL2200056	KL-A167注射液	tagitanlimab	Injection	Biological Products(1)	New Drug Application	2022-01-28		Sichuan Kelun-Biotech Biopharmaceutical Co Ltd			view
CXSL2200025	KL-A167注射液	tagitanlimab	Injection	Biological Products(1)	New Drug Application	2022-01-18		Sichuan Kelun-Biotech Biopharmaceutical Co Ltd			view
CXSL2101533	KL-A167注射液	tagitanlimab	Injection	Biological Products(1)	New Drug Application	2022-01-04		Sichuan Kelun-Biotech Biopharmaceutical Co Ltd			view
CXSL1700026	KL-A167注射液	tagitanlimab	Injection	Biological Products(1)	New Drug Application	2017-04-13	四川科伦博泰生物医药股份有限公司	Sichuan Kelun-Biotech Biopharmaceutical Co Ltd	Certificate Issued	2017-09-27	view